Capecitabine-Related Neurotoxicity Presenting as Trismus-Reference-Cited by-同舟云学术

Capecitabine-Related Neurotoxicity Presenting as Trismus

Published:2003-08 Issue:2 Volume:3 Page:121-123
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Couch Linda S.B.,Groteluschen David L.,Stewart James A.,Mulkerin Daniel L.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference19 articles.

1. Fluorinated pyrimidines, a new class of tumor inhibiting compounds;Heidelberger;Nature,1957

2. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study;Lokich;J Clin Oncol,1989

3. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma;Takebayashi;J Natl Cancer Inst,1996

4. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts;Ishikawa;Cancer Res,1998

5. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients;Schuller;Cancer Chemother Pharmacol,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrochemical sensor for sensitive detection of an anticancer drug Capecitabine by modified carbon paste electrode with tetrahydrodipyrazolo pyridine derivative and Cu-MCM-41 nanoparticles;Microchemical Journal;2024-04

2. Capecitabine related neurotoxicity: Clinical and radiologic features;Journal of the Neurological Sciences;2022-11

3. Reversible Toxic Encephalopathy Involving the Cerebellum and Subcortical White Matter Attributed to Capecitabine;The American Journal of the Medical Sciences;2022-04

4. Chemobrain: A review on mechanistic insight, targets and treatments;Advances in Cancer Research;2022

5. Neurological complications of systemic cancer and antineoplastic therapy;Neurological Complications of Systemic Cancer and Antineoplastic Therapy;2022